- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT00543452
Effect of Oxygen on Core Temperature
April 6, 2011 updated by: Umeå University
Study of the effect of oxygen on the frequency of central apnea, sleep and body temperature in patients with a cardiac disease
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
40
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Umeå, Sweden, SE 901 85
- Dept of Respiratory Medicine
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
- Older Adult
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Cardiac disease and Cheyne-Stokes respiration and controls without Cheyne-Stokes respiration
Exclusion Criteria:
- Obstructive sleep apnea
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Basic Science
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Quadruple
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Active Comparator: oxygen
4 liters of oxygen a minute
|
4 liters of oxygen a minute
|
Placebo Comparator: air
4 liters of room air
|
4 liters a minute of air from a placebo device
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Core temperature
Time Frame: One day
|
This is an experitmetal study.
Subjects receive oxygen or placebo-air during one night in random order.
Outcome measure, i.e.core temperatue is measured continuously during this night with ongoing treatment of oxygen or placebo-air
|
One day
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Sleep stages, apnea-hypopnea index
Time Frame: One day
|
This is an experitmetal study.
Subjects receive oxygen or placebo-air during one night in random order.
Outcome measure, i.e.the amount of differernt sleep stages, total sleep time and apnea-hypopnea index is measured during this night with ongoing treatment of oxygen or placebo-air
|
One day
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Collaborators
Investigators
- Principal Investigator: Karl A Franklin, MD, PhD, Dept Respiratory Medicine, University Hospital, Umeå
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
February 1, 2005
Primary Completion (Actual)
September 1, 2010
Study Completion (Actual)
September 1, 2010
Study Registration Dates
First Submitted
October 12, 2007
First Submitted That Met QC Criteria
October 12, 2007
First Posted (Estimate)
October 15, 2007
Study Record Updates
Last Update Posted (Estimate)
April 7, 2011
Last Update Submitted That Met QC Criteria
April 6, 2011
Last Verified
March 1, 2011
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 03-567
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Cheyne-Stokes Respiration
-
Assistance Publique - Hôpitaux de ParisCompleted
-
University of OsloResMedCompletedHeart Failure | Cheyne Stokes RespirationNorway
-
ResMedCompletedSubstudy on the Mechanistic Plausibility of the Clinical Benefits of Adaptive Servo-ventilation (MS)Heart Failure | Sleep Disorder | Cheyne Stokes RespirationAustralia, Germany, Switzerland, Netherlands, France, Finland, Czech Republic, United Kingdom
-
Respicardia, Inc.CompletedSleep Apnea | Sleep Disordered Breathing | Periodic Breathing | Central Sleep Apnea | Cheyne Stokes RespirationUnited States, Poland, Germany, Italy
-
ResMedCompletedCheyne-Stokes Respiration | Periodic BreathingGermany
-
Heart and Diabetes Center North-Rhine WestfaliaCompletedObstructive Sleep Apnoea | Cheyne Stokes Respiration | Central Sleep ApnoeaGermany
-
Umeå UniversityCompleted
-
ResMedCompletedCheyne-Stokes Respiration | Heart Failure, CongestiveAustralia
-
Heart and Diabetes Center North-Rhine WestfaliaTerminatedHigh-Flow-Therapy for the Treatment of Cheyne-Stokes-Respiration in Chronic Heart Failure (FLOAT-CS)Heart Failure,CongestiveGermany
-
Goethe UniversityCompletedEnvironmental Sleep Disorder | Cheyne-Stokes Respiration | Altitude SicknessGermany
Clinical Trials on Oxygen
-
National Baromedical ServicesMayo Clinic; Dartmouth-Hitchcock Medical Center; Eastern Virginia Medical School and other collaboratorsCompletedCarcinoma, Squamous Cell | Cancer of the Head and NeckUnited States
-
Aalborg University HospitalRigshospitalet, Denmark; Copenhagen Trial Unit, Center for Clinical Intervention...Active, not recruitingHypoxemic Respiratory Failure | Oxygen ToxicityNorway, Switzerland, Denmark
-
Aalborg University HospitalUniversity of AarhusUnknownCardiac Surgery | Cardiopulmonary Bypass | Acute Lung Injury | Hyperoxia | Oxygen ToxicityDenmark
-
Chang, Steve S., M.D.Santa Barbara Cottage HospitalCompletedPostoperative AbscessUnited States
-
Princess Margaret Hospital for ChildrenCompleted
-
Royal Brompton & Harefield NHS Foundation TrustLiverpool University Hospitals NHS Foundation Trust; National Institute for...CompletedLung; Disease, Fibroid (Chronic)United Kingdom
-
UMC UtrechtThe Netherlands Cancer InstituteCompletedBreast Cancer | Radiation ToxicityNetherlands
-
Heidelberg UniversityRecruitingPulmonary Arterial Hypertension | Oxygen Deficiency | CTEPHGermany
-
Aalborg University HospitalRigshospitalet, Denmark; Copenhagen Trial Unit, Center for Clinical Intervention...CompletedHypoxemic Respiratory Failure | Oxygen ToxicityUnited Kingdom, Denmark, Finland, Iceland, Netherlands, Norway, Switzerland
-
University Hospital Plymouth NHS TrustCompletedSepsisUnited Kingdom